HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Clearasil Anti-Acne Collection Expands With New Forms

This article was originally published in The Rose Sheet

Executive Summary

Boots Healthcare will add three products to its core Clearasil line in April, including the brand's first acne-fighting body wash, according to the firm

You may also be interested in...

Clearasil Launch Aims For Broader Control Of U.S. Skin Care Category

Boots Healthcare International is launching Clearasil Total Control, a non-acne treatment skin care range, to fill a void in the mass market for products that offer basic skin care benefits to young women, the company said during a press event in New York City Dec. 10

Boots Healthcare Gains Access To U.S. Market Through Clearasil Buy

Boots Healthcare International views its acquisition of the Clearasil acne prevention and treatment brand as a possible springboard for creating an OTC drug marketing presence in the U.S.

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts